Ping An Biomedical Statistics
Total Valuation
PASW has a market cap or net worth of $10.38 million. The enterprise value is $11.83 million.
Important Dates
The next estimated earnings date is Monday, January 12, 2026, after market close.
| Earnings Date | Jan 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
PASW has 20.50 million shares outstanding.
| Current Share Class | 20.50M |
| Shares Outstanding | 20.50M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 0.14% |
| Float | 5.64M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.10 |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 6.65 |
| P/OCF Ratio | 6.82 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.43 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 7.58 |
Financial Position
The company has a current ratio of 0.77
| Current Ratio | 0.77 |
| Quick Ratio | 0.50 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | 0.94 |
| Interest Coverage | -13.66 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -4.60% |
| Return on Invested Capital (ROIC) | -10.93% |
| Return on Capital Employed (ROCE) | 41.19% |
| Revenue Per Employee | $1.18M |
| Profits Per Employee | -$113,297 |
| Employee Count | 7 |
| Asset Turnover | 0.94 |
| Inventory Turnover | 48.72 |
Taxes
In the past 12 months, PASW has paid $82,438 in taxes.
| Income Tax | 82,438 |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 0.73 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 35.00 |
| Average Volume (20 Days) | 402,208 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, PASW had revenue of $8.29 million and -$793,081 in losses. Loss per share was -$0.04.
| Revenue | 8.29M |
| Gross Profit | 143,328 |
| Operating Income | -650,337 |
| Pretax Income | -710,644 |
| Net Income | -793,081 |
| EBITDA | -649,288 |
| EBIT | -650,337 |
| Loss Per Share | -$0.04 |
Full Income StatementBalance Sheet
The company has $15,111 in cash and $1.47 million in debt, giving a net cash position of -$1.45 million or -$0.07 per share.
| Cash & Cash Equivalents | 15,111 |
| Total Debt | 1.47M |
| Net Cash | -1.45M |
| Net Cash Per Share | -$0.07 |
| Equity (Book Value) | -1.62M |
| Book Value Per Share | -0.09 |
| Working Capital | -1.93M |
Full Balance SheetCash Flow
| Operating Cash Flow | 1.52M |
| Capital Expenditures | n/a |
| Free Cash Flow | 1.56M |
| FCF Per Share | $0.08 |
Full Cash Flow StatementMargins
Gross margin is 1.73%, with operating and profit margins of -7.85% and -9.57%.
| Gross Margin | 1.73% |
| Operating Margin | -7.85% |
| Pretax Margin | -8.58% |
| Profit Margin | -9.57% |
| EBITDA Margin | -7.84% |
| EBIT Margin | -7.85% |
| FCF Margin | 18.84% |